Today marks the launch of BMC Hematology within the BMC series of journals published by BioMed Central. Formerly known as BMC Blood Disorders, the journal was renamed in response to the feedback received from key opinion leaders in the field and in consultation with our Editorial Board. This change of name is intended to emphasize the journal’s commitment to representing the full breadth of disciplines and specialties in the hematology field in which rapidly evolving research findings translate into patient care. You can read more about the rationale behind this relaunch in this Editorial.
Since William Harvey introduced the then controversial concept of circulation in 1628, the field of hematology has come a long way. Important advances …
February 4th is World Cancer Day, a day dedicated to raising awareness and education about cancer, and encouraging governments and individuals across the world to take action against the disease. This year’s World Cancer Day will focus on Target 5 of the World Cancer Declaration: Dispel damaging myths and misconceptions about cancer. The aim is to improve general knowledge around cancer and dismiss misconceptions about the disease.
One in three people will be affected by cancer at some stage in their life. In 2008, there were 7.8 million cancer deaths and 12.7 million cancer cases. Without intervention, the global cancer burden is projected to increase by 75% in the next 20 years. Every …
BMC Cancer will be attending the Stem Cells in Cancer and Regenerative Medicine conference in EMBL Heidelberg, Germany from August 29th– September 1st.
This conference aims to describe the role of stem cells in normal and diseased physiology, as well as to give insights on how stem cells can be used for curative purposes. The overall aim is to integrate basic, translational and clinical aspects of stem cell research into a single framework.
It promises to be an exciting week of lively discussion, with topics such as cancer stem cells, pluripotency and tissue regeneration. Keynote speakers include John Dick, Azim Surani, Jane Visvader and many other international scientists.
If you are …
BMC Clinical Pathology and BMC Cancer will be attending the 1st European Symposium of Biopathology in Paris later this week. Biopathology is an emerging medical specialty based on innovating technologies combining molecular biology and pathology.
From the detection of circulating tumor cells to the identification of biomarkers for personalized medicine, international scientists including pathologists, oncologists and molecular biologists will gather to discuss the latest developments in molecular diagnosis in human pathology.
Get in touch and meet the Executive Editor of BMC Clinical Pathology and BMC Cancer in Paris (email@example.com). Whether you would like to discuss your latest research or are an experienced clinical pathologist interested in joining our …
This year saw BMC Cancer
turn ten. When the journal published its first volume of 20 articles in
2001 it was one of only a handful of open access titles operating in the field
and was exclusively run by a small team of in-house editors. A decade
later, the journal’s in-house team is supported by an international group of
Section Editors, Deputy Section Editors, Associate Editors and Editorial
Advisers numbering in the hundreds and has published nearly 3,000 articles.
To mark the end of its 10th year, BMC
Cancer is publishing a special anniversary
collection of commissioned articles. With contributions from Carlos Caldas,
Ian Cree, Shoukat Dedhar and many others,
the collection highlights …